Contractor
ASTRAZENECA PHARMACEUTICALS LP
WILMINGTON, DE
- UEI
- E5K2ZJ8CTJH4
- Parent UEI
- DZ9QEG2B98V6
- Resolved by
- uei
- Confidence
- 1.000
Obligated to date
$9,869,5921
Awards
4
Agencies served
2
Active from Sep 25, 2019 to Oct 7, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36F79719D0274 65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | Department of Veterans Affairs | — | Sep 25, 2019 | — |
| 36E79724D0026 NEW AWARD FOR ACALABRUTINIB TABLETS (100 MG) WITH ASTRAZENECA PHARMACEUTICALS, LP. PERIOD OF PERFORMANCE IS 06/24/2024 TO 06/23/2025 WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | Apr 24, 2024 | — |
| 75D30126D20713 ADULT FLU VACCINES | Department of Health and Human Services | — | Dec 29, 2025 | — |
| 75D30126D20723 PEDIATRIC FLU VACCINES | Department of Health and Human Services | — | Dec 29, 2025 | — |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier E5K2ZJ8CTJH4, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Oct 21, 2026.